Related references
Note: Only part of the references are listed.Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response
Thibault Fiolet et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Recommendations for antibacterial therapy in adults with COVID-19-an evidence based guideline
Elske Sieswerda et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial
Olivier Hermine et al.
JAMA INTERNAL MEDICINE (2021)
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial
Carlo Salvarani et al.
JAMA INTERNAL MEDICINE (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
Imad M. Tleyjeh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients
Steven P. Treon et al.
BLOOD (2020)
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
Adarsh Bhimraj et al.
CLINICAL INFECTIOUS DISEASES (2020)
COVID-19: don't neglect antimicrobial stewardship principles!
B. D. Huttner et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Mechanism of baricitinib supports artificial intelligence-predicted testing inCOVID-19 patients
Justin Stebbing et al.
EMBO MOLECULAR MEDICINE (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Lack of antiviral activity of darunavir against SARS-CoV-2
Sandra De Meyer et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19)
Sanket Shah et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2020)
COVID-19 and the potential long-term impact on antimicrobial resistance
Timothy M. Rawson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
SARS-CoV-2: a storm is raging
Savannah F. Pedersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Co-infections in people with COVID-19: a systematic review and meta-analysis
Louise Lansbury et al.
JOURNAL OF INFECTION (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Ishan Paranjpe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
Geoffrey D. Barnes et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Interferon beta-1b for COVID-19
Sarah Shalhoub
LANCET (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 A Randomized Trial
Caleb P. Skipper et al.
ANNALS OF INTERNAL MEDICINE (2020)
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting
S. Hughes et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
Xinyi Xia et al.
BLOOD (2020)
Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020
Heli Harvala et al.
EUROSURVEILLANCE (2020)
Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma A proof-of-concept, single-arm, multicenter trial .
Cesare Perotti et al.
HAEMATOLOGICA (2020)
Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series
Iris Navarro-Millan et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Antibiotic use in patients with COVID-19: a 'snapshot' Infectious Diseases International Research Initiative (ID-IRI) survey
Bojana Beovic et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
Michael J. Joyner et al.
MAYO CLINIC PROCEEDINGS (2020)
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
A. B. Cavalcanti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Girish N. Nadkarni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Anup Agarwal et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet et al.
LANCET RHEUMATOLOGY (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Operational considerations for case management of COVID-19 in health facility and community
[Anonymous]
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE (2020)
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
Noa Biran et al.
LANCET RHEUMATOLOGY (2020)
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
Ariane J. Brown et al.
ANTIVIRAL RESEARCH (2019)
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Theodoros Giavridis et al.
NATURE MEDICINE (2018)
Therapeutic Mechanisms of Glucocorticoids
Jolien Vandewalle et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09
Chandini Raina MacIntyre et al.
BMC INFECTIOUS DISEASES (2018)
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
Arthur Kavanaugh
Therapeutics and Clinical Risk Management (2016)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
